United States (US) Minor Cannabinoids Market (2025-2031) | Industry, Companies, Segmentation, Growth, Outlook, Size & Revenue, Share, Analysis, Value, Forecast, Trends, Competitive Landscape

Market Forecast By Product (Cannabigerol, Cannabichromene, Cannabinol, Tetrahydrocannabivarin), By Application (Inflammation, Pain Management, Neurological Disorders, Cancer, Others) And Competitive Landscape
Product Code: ETC9970594 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Minor Cannabinoids Market Outlook
  • Market Size of United States (US) Minor Cannabinoids Market, 2024
  • Forecast of United States (US) Minor Cannabinoids Market, 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Revenues & Volume for the Period 2021- 2031
  • United States (US) Minor Cannabinoids Market Trend Evolution
  • United States (US) Minor Cannabinoids Market Drivers and Challenges
  • United States (US) Minor Cannabinoids Price Trends
  • United States (US) Minor Cannabinoids Porter's Five Forces
  • United States (US) Minor Cannabinoids Industry Life Cycle
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Product for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Cannabigerol for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Cannabichromene for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Cannabinol for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Tetrahydrocannabivarin for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Inflammation for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Pain Management for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Neurological Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Minor Cannabinoids Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Minor Cannabinoids Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Application
  • United States (US) Minor Cannabinoids Top Companies Market Share
  • United States (US) Minor Cannabinoids Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Minor Cannabinoids Company Profiles
  • United States (US) Minor Cannabinoids Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Minor Cannabinoids Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Minor Cannabinoids Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Minor Cannabinoids Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Minor Cannabinoids Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Minor Cannabinoids Market - Industry Life Cycle

3.4 United States (US) Minor Cannabinoids Market - Porter's Five Forces

3.5 United States (US) Minor Cannabinoids Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Minor Cannabinoids Market Revenues & Volume Share, By Application, 2021 & 2031F

4 United States (US) Minor Cannabinoids Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing consumer awareness about the potential health benefits of minor cannabinoids

4.2.2 Growing acceptance of cannabis-derived products for medicinal and wellness purposes

4.2.3 Legalization of hemp and CBD products, leading to a wider acceptance of minor cannabinoids

4.3 Market Restraints

4.3.1 Regulatory uncertainties and evolving legal landscape surrounding cannabinoids

4.3.2 Lack of standardized quality control measures for minor cannabinoids products

5 United States (US) Minor Cannabinoids Market Trends

6 United States (US) Minor Cannabinoids Market, By Types

6.1 United States (US) Minor Cannabinoids Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Minor Cannabinoids Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Minor Cannabinoids Market Revenues & Volume, By Cannabigerol, 2021- 2031F

6.1.4 United States (US) Minor Cannabinoids Market Revenues & Volume, By Cannabichromene, 2021- 2031F

6.1.5 United States (US) Minor Cannabinoids Market Revenues & Volume, By Cannabinol, 2021- 2031F

6.1.6 United States (US) Minor Cannabinoids Market Revenues & Volume, By Tetrahydrocannabivarin, 2021- 2031F

6.2 United States (US) Minor Cannabinoids Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Minor Cannabinoids Market Revenues & Volume, By Inflammation, 2021- 2031F

6.2.3 United States (US) Minor Cannabinoids Market Revenues & Volume, By Pain Management, 2021- 2031F

6.2.4 United States (US) Minor Cannabinoids Market Revenues & Volume, By Neurological Disorders, 2021- 2031F

6.2.5 United States (US) Minor Cannabinoids Market Revenues & Volume, By Cancer, 2021- 2031F

6.2.6 United States (US) Minor Cannabinoids Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Minor Cannabinoids Market Import-Export Trade Statistics

7.1 United States (US) Minor Cannabinoids Market Export to Major Countries

7.2 United States (US) Minor Cannabinoids Market Imports from Major Countries

8 United States (US) Minor Cannabinoids Market Key Performance Indicators

8.1 Number of clinical trials and research studies conducted on minor cannabinoids

8.2 Adoption rate of minor cannabinoids products by mainstream retailers

8.3 Amount of investment in research and development for minor cannabinoids formulations

9 United States (US) Minor Cannabinoids Market - Opportunity Assessment

9.1 United States (US) Minor Cannabinoids Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Minor Cannabinoids Market Opportunity Assessment, By Application, 2021 & 2031F

10 United States (US) Minor Cannabinoids Market - Competitive Landscape

10.1 United States (US) Minor Cannabinoids Market Revenue Share, By Companies, 2024

10.2 United States (US) Minor Cannabinoids Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All